STOCK TITAN

Codexis (NASDAQ: CDXS) CSO Lutz sells 4,685 shares to cover tax liability

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Codexis, Inc. CSO Stefan Lutz reported selling 4,685 shares of Codexis common stock on January 7, 2026 at a price of $1.6968 per share. According to the disclosure, this sale was made to cover tax liabilities arising from the vesting and release of restricted stock units held by him. After this transaction, Lutz beneficially owned 138,775 shares of Codexis common stock, which includes 41,633 restricted stock units, all held directly.

Positive

  • None.

Negative

  • None.
Insider Lutz Stefan
Role CSO
Sold 4,685 shs ($8K)
Type Security Shares Price Value
Sale Common Stock 4,685 $1.6968 $8K
Holdings After Transaction: Common Stock — 138,775 shares (Direct)
Footnotes (1)
  1. The sale reported on this Form 4 was effected to cover tax liability incurred due to the vesting and release of Restricted Stock Units held by the Reporting Person. Includes 41,633 restricted stock units.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lutz Stefan

(Last) (First) (Middle)
C/O CODEXIS, INC.
200 PENOBSCOT DRIVE

(Street)
REDWOOD CITY CA 94063

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CSO
3. Date of Earliest Transaction (Month/Day/Year)
01/07/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/07/2026 S(1) 4,685 D $1.6968 138,775(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported on this Form 4 was effected to cover tax liability incurred due to the vesting and release of Restricted Stock Units held by the Reporting Person.
2. Includes 41,633 restricted stock units.
/s/ Georgia Erbez, as Attorney-in-Fact for Stefan Lutz 01/08/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Codexis (CDXS) report for Stefan Lutz?

Codexis reported that CSO Stefan Lutz sold 4,685 shares of its common stock on January 7, 2026 at $1.6968 per share.

Why did Codexis CSO Stefan Lutz sell 4,685 shares of CDXS stock?

The company disclosed that the sale was effected to cover tax liability incurred from the vesting and release of restricted stock units held by Stefan Lutz.

How many Codexis (CDXS) shares does Stefan Lutz own after this Form 4 transaction?

After the reported sale, Stefan Lutz beneficially owned 138,775 shares of Codexis common stock, including 41,633 restricted stock units, held directly.

What type of security did Stefan Lutz sell in this Codexis Form 4 filing?

The transaction involved Codexis common stock, reported as a non-derivative security in the Form 4 filing.

Is the Stefan Lutz transaction in Codexis (CDXS) stock direct or indirect ownership?

The filing states that the 4,685 shares sold and the 138,775 shares beneficially owned following the transaction are held under direct ownership.

What role does Stefan Lutz hold at Codexis (CDXS) in this insider filing?

In this Form 4, Stefan Lutz is identified as an officer of Codexis, serving as its Chief Scientific Officer (CSO).